Next Article in Journal
Vaccines against Genital Herpes: Where Are We?
Next Article in Special Issue
Antiretroviral Therapy Interruption (ATI) in HIV-1 Infected Patients Participating in Therapeutic Vaccine Trials: Surrogate Markers of Virological Response
Previous Article in Journal
Expression of Concern: Artigas-Jerónimo et al. A Novel Combined Scientific and Artistic Approach for the Advanced Characterization of Interactomes: The Akirin/Subolesin Model. Vaccines 2020, 8, 77
Previous Article in Special Issue
Characterization of Physicians That Might Be Reluctant to Propose HIV Cure-Related Clinical Trials with Treatment Interruption to Their Patients? The ANRS-APSEC Study
 
 
Review

Article Versions Notes

Vaccines 2020, 8(3), 419; https://doi.org/10.3390/vaccines8030419
Action Date Notes Link
article xml file uploaded 27 July 2020 09:53 CEST Original file -
article xml uploaded. 27 July 2020 09:53 CEST Update -
article pdf uploaded. 27 July 2020 09:53 CEST Version of Record -
article xml file uploaded 27 July 2020 09:53 CEST Update -
article xml uploaded. 27 July 2020 09:53 CEST Update https://www.mdpi.com/2076-393X/8/3/419/xml
article pdf uploaded. 27 July 2020 09:53 CEST Updated version of record https://www.mdpi.com/2076-393X/8/3/419/pdf
article html file updated 27 July 2020 09:54 CEST Original file -
article html file updated 27 July 2020 09:54 CEST Update -
article html file updated 22 July 2022 01:25 CEST Update https://www.mdpi.com/2076-393X/8/3/419/html
Back to TopTop